Brief: Biogen Expands Immunology Pipeline With Agreement To Acquire Raythera Inc.
BRIEF-Biogen Expands Immunology Pipeline With Agreement To Acquire Raythera Inc. June 17 (Reuters) - Biogen Inc BIIB.O:
BIOGEN EXPANDS IMMUNOLOGY PIPELINE WITH AGREEMENT TO ACQUIRE RAYTHERA INC.
BIOGEN - TO BUY RAYTHERA FOR UP TO $1 BILLION INCLUDING MILESTONE PAYMENTS
BIOGEN - RAYTHERA LEAD CANDIDATE TO ENTER PHASE 1 DEVELOPMENT IN EARLY Q3 2026
BIOGEN - TO LEAD DEVELOPMENT AND COMMERCIALIZATION OF RAYTHERA ASSETS AFTER CLOSING
Source text: ID:nGNX6Pj1tJ
Further company coverage: BIIB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biogen
See all newsUS RESEARCH ROUNDUP-Autodesk, Metlife, Rollins
Brief: Biogen Says DZP Plus Soc Meets Primary Endpoint Of BICLA Response At Week 48
Brief: Biogen Provides Update On Private Payer Coverage For Zurzuvae™ (Zuranolone)
US RESEARCH ROUNDUP-Eli Lilly, General Dynamics, S&P Global
US RESEARCH ROUNDUP-Baker Hughes, Brinker International, GE Vernova